INOVIE GROUP
- Company typePrivate
- Founded2010
- HeadquartersMontpellier, France
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
INOVIE GROUP firmographics
Firmographics- Name
- INOVIE GROUP
- Legal name
- INOVIE Group SAS
- Website
- https://inovie.fr
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
INOVIE GROUP industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
- akta.pro secondary industries
- Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN), Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity) (HLAHAAAO)
Keywords
Where INOVIE GROUP is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Offices20 records
Markets served
INOVIE GROUP business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Laboratory Medical Biology Services: Revenue generated from performing medical biology analyses billed to social security and health insurance systems. Services include routine blood tests, specialized analyses, genetic testing, and pathology examinations. National Health Insurance (Assurance Maladie) and supplementary health insurers reimburse patients for covered analyses.
- Patient Direct Services: Direct patient services including STI screening, without prescription tests, and specialized diagnostics. Some services covered by national insurance, others may have supplemental insurance coverage or minor patient contributions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | STI screening without prescription for under-26 |
| Transaction based/ take rate | Pay-as-you-go | STI screening without prescription for over-26 |
| One time/ perpetual license | Pay-as-you-go | Postal result delivery |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
INOVIE GROUP product offering
Product offeringCore offering
INOVIE GROUP operates a France-wide network of more than 557 medical biology proximity laboratories and 65 high-performance technical platforms, providing diagnostic testing services including routine blood analyses, genetics, anatomopathology, STI screening, COVID-19 testing, and fertility diagnostics to individual patients, healthcare professionals, and partner healthcare institutions. The company also delivers digital result access through its INOVIE +me unified patient portal and deploys the Dedalus InVitro laboratory information management suite across its subsidiaries.
Product overview
INOVIE GROUP operates a platform-plus-modules architecture centered on a France-wide network of medical biology diagnostic laboratories. The core offering is the network of over 557 proximity laboratory sites and 65 high-performance technical platforms organized across 25 regional subsidiary brands. The unified patient-facing layer is the INOVIE +me digital platform, which provides a single portal for result access and lab management across all subsidiaries. Supporting modules include dedicated IST screening services (sans ordonnance, covering HIV, hepatitis B, syphilis, chlamydia, gonorrhea), COVID-19 testing, and INOVIE Fertility reproductive health services. The group also deploys the Dedalus InVitro Suite in SaaS mode for laboratory information management across medical biology, genetics, and anatomopathology. The subsidiary lab brands (INOVIE Labosud, INOVIE Biopyrénées, INOVIE CBM, INOVIE GEN-BIO, INOVIE BioMedilab, INOVIE Biofutur, INOVIE Bio-clinic, INOVIE Bioaxiome, INOVIE Axbio, INOVIE BIOLYSS, INOVIE Biopôle Antilles, INOVIE Labosud Provence, INOVIE Nealab, INOVIE Ocealab, INOVIE ProLAB, INOVIE RéuniLAB, INOVIE SynAIRBIO, and INOVIE Guevalt) represent regional sub-brands of the same laboratory service, consolidated under the INOVIE umbrella following multiple acquisitions.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Biology Diagnostic Laboratory Network
- INOVIE +me Patient Portal
- IST Screening Services (sans ordonnance)
- COVID-19 Testing Services
- INOVIE Fertility (INOVIE Fertilité)
- Chronic Kidney Disease (CKD) Screening
- Pertussis (Coqueluche) PCR Testing
- Dedalus InVitro Laboratory Suite
Quantifiable outcome
- 557 laboratory sites and 65 technical platforms serving patients across France
- +3 more outcomes
Companies that use INOVIE GROUP
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
INOVIE GROUP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
INOVIE GROUP partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and major.
- DedaluscoreFive-year strategic partnership for large-scale deployment of Dedalus InVitro suite in SaaS mode. INOVIE laboratories will gain access to comprehensive platform covering medical biology, genetics, and anatomopathology, including result servers, quality management tools, administrative and billing functions, and decision-support tools. Both parties describe this as a key step in INOVIE's digital transformation aimed at improving performance for patients and healthcare professionals.
- BiofuturmajorINOVIE is in the process of acquiring Biofutur, which operates approximately 60 laboratory sites in Île-de-France and generates annual revenue of 90 million euros. This acquisition would significantly expand INOVIE's presence in the Greater Paris region.
Scale indicators4 records
Recent moves13 records
Expansion highlights6 records
INOVIE GROUP competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global leader in bioanalytical testing with significant clinical diagnostics and genomic services alongside its broader food/environment/pharma testing portfolio. Comparable to INOVIE in clinical and specialty diagnostics scale but much broader in scope.
- Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering highly specialized and esoteric testing globally. Comparable to INOVIE in specialized diagnostics and genetics, though more focused on reference/rare-disease testing rather than walk-in routine biology.
- Sonic Healthcare: Australia-headquartered global medical diagnostics provider with extensive laboratory networks in Europe (including Germany, UK, Switzerland, Belgium). Comparable as a large multi-country clinical laboratory operator with similar scale economics and service mix.
- Quest Diagnostics: US-based leading clinical laboratory services company with broad routine and specialty testing menus. Comparable to INOVIE in clinical biology operations, patient-direct services, and digital result delivery platforms, though at significantly larger scale and concentrated in North America.
- Labcorp (Laboratory Corporation of America): One of the world's largest clinical laboratory networks, offering routine and esoteric diagnostics across the US and internationally. Comparable to INOVIE in routine and specialty biology services, lab consolidation strategy, and prescriber-facing digital tools, though operating at much greater scale.
Direct peers
- Biogroup: Leading French private medical biology laboratory network with hundreds of sites across France. Directly competes with INOVIE in routine biology, screening services, and the same reimbursement/regulatory framework, pursuing a similar regional-rollup strategy.
- Cerba HealthCare: French-headquartered specialty and routine clinical laboratory group with strong presence in France, Belgium, and Luxembourg. Closely comparable to INOVIE in terms of French market positioning, routine and specialty biology services, and hospital/clinic partnerships.
- Synlab: Europe's largest medical diagnostics services provider, operating clinical laboratory networks across multiple countries. Directly comparable to INOVIE as a pan-European rollup of regional medical biology laboratories serving both patients and prescribers.
- Unilabs: Major European clinical laboratory network operating across 15+ countries with routine and specialty testing services. Comparable to INOVIE as a multi-country rollup focused on medical biology, with significant operations in France via Unilabs France.
Regional players
- Medipath: French pathology and anatomic pathology laboratory network. Comparable to INOVIE's anatomopathology line of business and operates in the same French regulatory and reimbursement environment, though narrower in scope (focused on pathology).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
INOVIE GROUP social profiles
Digital presenceINOVIE GROUP compliance and trust
Trust signalCompliance2 records
INOVIE GROUP financial estimates
Financial estimateRevenue estimate
Valuation estimate
INOVIE GROUP leadership team
Management profileNumber of profiles
Profiles1 record
INOVIE GROUP subsidiaries and ownership
Company hierarchySubsidiaries22 records
INOVIE GROUP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
INOVIE GROUP M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about INOVIE GROUP
What does INOVIE GROUP do?
INOVIE GROUP operates a France-wide network of more than 557 medical biology proximity laboratories and 65 high-performance technical platforms, providing diagnostic testing services including routine blood analyses, genetics, anatomopathology, STI screening, COVID-19 testing, and fertility diagnostics to individual patients, healthcare professionals, and partner healthcare institutions. The company also delivers digital result access through its INOVIE +me unified patient portal and deploys the Dedalus InVitro laboratory information management suite across its subsidiaries.
Is INOVIE GROUP a public or private company?
INOVIE GROUP is a private company. It is classified as unknown and is currently operating.
When was INOVIE GROUP founded?
INOVIE GROUP was founded in 2010. It employs 5,001 to 10,000 people.
Where is INOVIE GROUP based?
INOVIE GROUP is headquartered in Montpellier, France, in the Europe region.
How does INOVIE GROUP make money?
Two revenue lines are on record. Laboratory Medical Biology Services are the primary driver. The others are patient Direct Services.
Who are INOVIE GROUP's main competitors?
Broad incumbents on record are Eurofins Scientific, Mayo Clinic Laboratories, Sonic Healthcare, Quest Diagnostics and Labcorp (Laboratory Corporation of America). Direct peers are Biogroup, Cerba HealthCare, Synlab and Unilabs. Medipath is listed as a regional player.
Does INOVIE GROUP have an API?
No public API is recorded for INOVIE GROUP.
What industry is INOVIE GROUP in?
INOVIE GROUP's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLAJAIAM, Laboratory Quality Systems, Accreditation & Proficiency Testing Programs. Its NAICS code is 621511 and its SIC code is 8071.